Company Overview of Kymab Limited
Kymab Limited, a biopharmaceutical company, engages in the discovery and development of human monoclonal antibody therapeutics. The company is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. The company focuses on using the Kymouse platform for the discovery, development, and commercialization of antibody based medicines. Kymab Limited was founded in 2009 and is based in Cambridge, United Kingdom.
Babraham Research Campus
Cambridge, CB22 3AT
Founded in 2009
44 1223 833301
44 1223 839133
Key Executives for Kymab Limited
Kymab Limited Key Developments
Similar Private Companies By Industry
|Biocompatibles International Ltd.||Europe|
|Orla Protein Technologies Ltd||Europe|
|Lab M Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Kymab Limited, please visit www.kymab.com. Company data is provided by Capital IQ. Please use this form to report any data issues.